Evaluating the preclinical efficacy of multi-tyrosine kinase inhibitor TT-00420 in hormone therapy-resistant prostate cancer
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
TransThera Biosciences Co. Ltd
Start Date
January 12, 2024
End Date
July 11, 2024
Administered By
Medicine, Medical Oncology
Awarded By
TransThera Biosciences Co. Ltd
Start Date
January 12, 2024
End Date
July 11, 2024